Mazdutide

SAN FRANCISCO and SUZHOU, China, May 12, 2026 Innovent Biologics announced that it will present multiple clinical and preclinical...

BEIJING, December 2025 — New Phase 1b clinical data show that mazdutide, an investigational metabolic therapy, delivered significant weight-loss...

BEIJING, China, Nov. 25, 2025 — Innovent Biologics and Eli Lilly announced that the supplementary application for Mazdutide 9mg...